French-German biotech SMEY launches Lipid Atlas, an AI-powered platform designed to accelerate lipidomics research, biomarker discovery and precision medicine.
Author: Elyse Christian
Paris-based biotech startup Generare secures €20M to generate novel molecular data by decoding microbial genomes, aiming to speed and de-risk drug development.
Zurich neurotech startup Connectome raises $2M pre-seed led by Redstone to continuously track brain health and detect up to 70% of silent cognitive decline.
Top European space founders and investors will share market insights, funding trends and deeptech breakthroughs at the EU-Startups Summit 2026 panel on space innovation.
Metafuels secures a €1.92M Dutch government grant to accelerate development of an e-SAF plant in Rotterdam, boosting sustainable aviation fuel innovation in Europe.
Alice & Bob lands major ARPA-E funding for next-gen magnets French quantum startup Alice & Bob has secured a €3.4 million award from the U.S. Department of Energy’s Advanced Research Projects Agency-Energy (ARPA-E) to accelerate the discovery of rare-earth-free permanent magnets using advanced quantum computing techniques. Tackling the rare-earth dependency in critical materials Permanent magnets are essential components in electric vehicles, wind turbines, consumer electronics and a wide range of industrial systems. Today, many of the highest-performance magnets rely on rare earth elements, a supply chain dominated by a small number of producing countries and exposed to price volatility, export…
UK startup Semarion secures £2.9M led by Parkwalk to scale its SemaCyte cell assay platform, aiming to cut time and cost in early-stage drug discovery.
New climate tech and AI tools are arming homeowners with real-time wildfire risk data, predictive insights and home-hardening solutions as fire seasons intensify.
Female leaders are reshaping AgriTech, but funding gaps, bias and tech access still slow their rise. Here’s where the real opportunities and obstacles lie.
European startup R3 Bio is betting on humane biotech, using advanced cell models to cut animal testing while speeding safer, more predictive drug discovery.